Genetic polymorphisms influence the ovarian response to rfsh stimulation in patients undergoing in vitro fertilization programs with ICSI

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Boudjenah, Radia ^a,b   Molina Gomes, Denise ^a,b   Torre, Antoine ^a,b   Bergere, Marianne ^a,b   Bailly, Marc ^a,b   Boitrelle, Florence ^a,b   Taieb, Stéphane ^b   Wainer, Robert ^a,b   Benahmed, Mohamed ^c   de Mazancourt, Philippe ^b   Selva, Jacqueline ^a,b   Vialard, François ^a,b  

^a Department of Reproductive Biology Cytogenetics Gynaecology and Obstetrics   (France)

^b INRA Institut National de la Recherche Agronomique   (France)

^c UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BONE MORPHOGENETIC PROTEIN 15; FOLLITROPIN; FOLLITROPIN RECEPTOR; GONALF; MUELLERIAN INHIBITING FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN P53; RECOMBINANT FOLLITROPIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; ESTROGEN RECEPTOR BETA; PRIMER DNA;

ADULT; AMH GENE; AMHR GENE; ARTICLE; BMP15 GENE; CONTROLLED STUDY; ESR1 GENE; ESR2 GENE; FEMALE; FERTILIZATION IN VITRO; FSHR GENE; GENOTYPE GENE; HLA G GENE; HUMAN; HUMAN CELL; INTRACYTOPLASMIC SPERM INJECTION; MTHFR1 GENE; MTHFR2 GENE; MULTIPLEX POLYMERASE CHAIN REACTION; OOCYTE MATURATION; P53 GENE; PAI 1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TNF ALPHA GENE; VEGF GENE; AGE; BLOOD; CAUCASIAN; DRUG EFFECT; GENE FREQUENCY; GENETICS; GENOTYPE; METABOLISM; METHODOLOGY; MULTIVARIATE ANALYSIS; OOCYTE; OVARY; POLYMERASE CHAIN REACTION;

AGE FACTORS; DNA PRIMERS; ESTROGEN RECEPTOR BETA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GENE FREQUENCY; GENOTYPE; HUMANS; MULTIVARIATE ANALYSIS; OOCYTES; OVARY; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, FSH; SPERM INJECTIONS, INTRACYTOPLASMIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84862175839     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038700     Document Type: Article

References (66)

1. Grady R, Alavi N, Vale R, Khandwala M, McDonald SD, (2012) Elective single embryo transfer and perinatal outcomes: a systematic review and meta-analysis. Fertil Steril 97: 324-331.
2. Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, et al. (1989) Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 51: 651-654.
3. Licciardi FL, Liu HC, Rosenwaks Z, (1995) Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril 64: 991-994.
4. Hofmann GE, Danforth DR, Seifer DB, (1998) Inhibin-B: the physiologic basis of the clomiphene citrate challenge test for ovarian reserve screening. Fertil Steril 69: 474-477.
5. Ficicioglu C, Kutlu T, Baglam E, Bakacak Z, (2006) Early follicular antimullerian hormone as an indicator of ovarian reserve. Fertil Steril 85: 592-596.
6. Schwartz D, Mayaux MJ, (1982) Female fecundity as a function of age: results of artificial insemination in 2193 nulliparous women with azoospermic husbands. Federation CECOS. N Engl J Med 306: 404-406.
7. Hendriks DJ, Mol BW, Bancsi LF, Te Velde ER, Broekmans FJ, (2005) Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil Steril 83: 291-301.
8. Scott RT Jr, Hofmann GE, Oehninger S, Muasher SJ, (1990) Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertil Steril 54: 297-302.
9. Ocal P, Aydin S, Cepni I, Idil S, Idil M, et al. (2004) Follicular fluid concentrations of vascular endothelial growth factor, inhibin A and inhibin B in IVF cycles: are they markers for ovarian response and pregnancy outcome? Eur J Obstet Gynecol Reprod Biol 115: 194-199.
10. Srouji SS, Mark A, Levine Z, Betensky RA, Hornstein MD, et al. (2005) Predicting in vitro fertilization live birth using stimulation day 6 estradiol, age, and follicle-stimulating hormone. Fertil Steril 84: 795-797.
11. de Castro F, Ruiz R, Montoro L, Perez-Hernandez D, Sanchez-Casas Padilla E, et al. (2003) Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone. Fertil Steril 80: 571-576.
12. Behre HM, Greb RR, Mempel A, Sonntag B, Kiesel L, et al. (2005) Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics 15: 451-456.
13. de Castro F, Moron FJ, Montoro L, Galan JJ, Hernandez DP, et al. (2004) Human controlled ovarian hyperstimulation outcome is a polygenic trait. Pharmacogenetics 14: 285-293.
14. Kevenaar ME, Themmen AP, Laven JS, Sonntag B, Fong SL, et al. (2007) Anti-Mullerian hormone and anti-Mullerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women. Hum Reprod 22: 1547-1554.
15. Altmae S, Hovatta O, Stavreus-Evers A, Salumets A, (2011) Genetic predictors of controlled ovarian hyperstimulation: where do we stand today? Hum Reprod Update 17: 813-828.
16. Simoni M, Nieschlag E, Gromoll J, (2002) Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. Hum Reprod Update 8: 413-421.
17. Perez Mayorga M, Gromoll J, Behre HM, Gassner C, Nieschlag E, et al. (2000) Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab 85: 3365-3369.
18. Greb RR, Behre HM, Simoni M, (2005) Pharmacogenetics in ovarian stimulation- current concepts and future options. Reprod Biomed Online 11: 589-600.
19. Sudo S, Kudo M, Wada S, Sato O, Hsueh AJ, et al. (2002) Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol Hum Reprod 8: 893-899.
20. Laven JS, Mulders AG, Suryandari DA, Gromoll J, Nieschlag E, et al. (2003) Follicle-stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility. Fertil Steril 80: 986-992.
21. Loutradis D, Patsoula E, Stefanidis K, Drakakis P, Antonakis G, et al. (2006) Follicle-stimulating hormone receptor gene mutations are not evident in Greek women with premature ovarian failure and poor responders. Gynecol Obstet Invest 61: 56-60.
22. Achrekar SK, Modi DN, Desai SK, Mangoli VS, Mangoli RV, et al. (2009) Follicle-stimulating hormone receptor polymorphism (Thr307Ala) is associated with variable ovarian response and ovarian hyperstimulation syndrome in Indian women. Fertil Steril 91: 432-439.
23. Anagnostou E, Mavrogianni D, Theofanakis C, Drakakis P, Bletsa R,et al. ESR1, ESR2 and FSH Receptor Gene Polymorphisms in Combination: A Useful Genetic Tool for the Prediction of Poor Responders. Curr Pharm Biotechnol.
24. Daelemans C, Smits G, de Maertelaer V, Costagliola S, Englert Y, et al. (2004) Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism. J Clin Endocrinol Metab 89: 6310-6315.
25. Kevenaar ME, Laven JS, Fong SL, Uitterlinden AG, de Jong FH, et al. (2008) A functional anti-mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients. J Clin Endocrinol Metab 93: 1310-1316.
26. Durlinger AL, Visser JA, Themmen AP, (2002) Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction 124: 601-609.
27. Gigli I, Cushman RA, Wahl CM, Fortune JE, (2005) Evidence for a role for anti-Mullerian hormone in the suppression of follicle activation in mouse ovaries and bovine ovarian cortex grafted beneath the chick chorioallantoic membrane. Mol Reprod Dev 71: 480-488.
28. Carlsson IB, Scott JE, Visser JA, Ritvos O, Themmen AP, et al. (2006) Anti-Mullerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro. Hum Reprod 21: 2223-2227.
29. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Kumar TR, et al. (2001) Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 142: 4891-4899.
30. Visser JA, Durlinger AL, Peters IJ, van den Heuvel ER, Rose UM, et al. (2007) Increased oocyte degeneration and follicular atresia during the estrous cycle in anti-Mullerian hormone null mice. Endocrinology 148: 2301-2308.
31. Sundarrajan C, Liao WX, Roy AC, Ng SC, (2001) Association between estrogen receptor-beta gene polymorphisms and ovulatory dysfunctions in patients with menstrual disorders. J Clin Endocrinol Metab 86: 135-139.
32. Byers M, Kuiper GG, Gustafsson JA, Park-Sarge OK, (1997) Estrogen receptor-beta mRNA expression in rat ovary: down-regulation by gonadotropins. Mol Endocrinol 11: 172-182.
33. Drummond AE, Findlay JK, (1999) The role of estrogen in folliculogenesis. Mol Cell Endocrinol 151: 57-64.
34. Hegele-Hartung C, Siebel P, Peters O, Kosemund D, Muller G, et al. (2004) Impact of isotype-selective estrogen receptor agonists on ovarian function. Proc Natl Acad Sci U S A 101: 5129-5134.
35. Ireland JJ, Richards JS, (1978) Acute effects of estradiol and follicle-stimulating hormone on specific binding of human [125I]iodofollicle-stimulating hormone to rat ovarian granulosa cells in vivo and in vitro. Endocrinology 102: 876-883.
36. Windahl SH, Andersson G, Gustafsson JA, (2002) Elucidation of estrogen receptor function in bone with the use of mouse models. Trends Endocrinol Metab 13: 195-200.
37. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, et al. (1998) Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci U S A 95: 15677-15682.
38. Scully KM, Gleiberman AS, Lindzey J, Lubahn DB, Korach KS, et al. (1997) Role of estrogen receptor-alpha in the anterior pituitary gland. Mol Endocrinol 11: 674-681.
39. Putnik M, Zhao C, Gustafsson JA, Dahlman-Wright K, (2009) Effects of two common polymorphisms in the 3′ untranslated regions of estrogen receptor beta on mRNA stability and translatability. BMC Genet 10: 55.
40. Fishel SB, Edwards RG, Walters DE, (1983) Follicular steroids as a prognosticator of successful fertilization of human oocytes in vitro. J Endocrinol 99: 335-344.
41. Botero-Ruiz W, Laufer N, DeCherney AH, Polan ML, Haseltine FP, et al. (1984) The relationship between follicular fluid steroid concentration and successful fertilization of human oocytes in vitro. Fertil Steril 41: 820-826.
42. Ollmann M, Young LM, Di Como CJ, Karim F, Belvin M, et al. (2000) Drosophila p53 is a structural and functional homolog of the tumor suppressor p53. Cell 101: 91-101.
43. Derry WB, Putzke AP, Rothman JH, (2001) Caenorhabditis elegans p53: role in apoptosis, meiosis, and stress resistance. Science 294: 591-595.
44. Kay C, Jeyendran RS, Coulam CB, (2006) p53 tumour suppressor gene polymorphism is associated with recurrent implantation failure. Reprod Biomed Online 13: 492-496.
45. Aghajanova L, (2004) Leukemia inhibitory factor and human embryo implantation. Ann N Y Acad Sci 1034: 176-183.
46. Laird SM, Tuckerman EM, Dalton CF, Dunphy BC, Li TC, et al. (1997) The production of leukaemia inhibitory factor by human endometrium: presence in uterine flushings and production by cells in culture. Hum Reprod 12: 569-574.
47. Mikolajczyk M, Wirstlein P, Skrzypczak J, (2007) The impact of leukemia inhibitory factor in uterine flushing on the reproductive potential of infertile women-a prospective study. Am J Reprod Immunol 58: 65-74.
48. Kang HJ, Hu W, Levine A, Rosenwaks Z, (2008) The G-&c polymorphism of the p53 gene is strongly associated with decreased pregnancy rates in fresh IVF patients via an ovarian mechanism. Fertil Steril 92: S21.
49. Holm S, (1979) A simple sequentially rejective multiple test procedure. Scand J Stat 6: 65-70.
50. Hanevik HI, Hilmarsen HT, Skjelbred CF, Tanbo T, Kahn JA Single nucleotide polymorphisms in the anti-Mullerian hormone signalling pathway do not determine high or low response to ovarian stimulation. Reprod Biomed Online 21: 616-623.
51. Moron FJ, de Castro F, Royo JL, Montoro L, Mira E, et al. (2006) Bone morphogenetic protein 15 (BMP15) alleles predict over-response to recombinant follicle stimulation hormone and iatrogenic ovarian hyperstimulation syndrome (OHSS). Pharmacogenet Genomics 16: 485-495.
52. Altmae S, Haller K, Peters M, Hovatta O, Stavreus-Evers A, et al. (2007) Allelic estrogen receptor 1 (ESR1) gene variants predict the outcome of ovarian stimulation in in vitro fertilization. Mol Hum Reprod 13: 521-526.
53. Sundarrajan C, Liao W, Roy AC, Ng SC, (1999) Association of oestrogen receptor gene polymorphisms with outcome of ovarian stimulation in patients undergoing IVF. Mol Hum Reprod 5: 797-802.
54. Jun JK, Yoon JS, Ku SY, Choi YM, Hwang KR, et al. (2006) Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET. J Hum Genet 51: 665-670.
55. Conway GS, Conway E, Walker C, Hoppner W, Gromoll J, et al. (1999) Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome. Clin Endocrinol (Oxf) 51: 97-99.
56. Greb RR, Grieshaber K, Gromoll J, Sonntag B, Nieschlag E, et al. (2005) A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metab 90: 4866-4872.
57. Klinkert ER, te Velde ER, Weima S, van Zandvoort PM, Hanssen RG, et al. (2006) FSH receptor genotype is associated with pregnancy but not with ovarian response in IVF. Reprod Biomed Online 13: 687-695.
58. Roussev RG, Coulam CB, (2007) HLA-G and its role in implantation (review). J Assist Reprod Genet 24: 288-295.
59. Thaler CJ, Budiman H, Ruebsamen H, Nagel D, Lohse P, (2006) Effects of the common 677C>T mutation of the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene on ovarian responsiveness to recombinant follicle-stimulating hormone. Am J Reprod Immunol 55: 251-258.
60. Rosen MP, Shen S, McCulloch CE, Rinaudo PF, Cedars MI, et al. (2007) Methylenetetrahydrofolate reductase (MTHFR) is associated with ovarian follicular activity. Fertil Steril 88: 632-638.
61. Azem F, Many A, Ben Ami I, Yovel I, Amit A, et al. (2004) Increased rates of thrombophilia in women with repeated IVF failures. Hum Reprod 19: 368-370.
62. Martinelli I, Taioli E, Ragni G, Levi-Setti P, Passamonti SM, et al. (2003) Embryo implantation after assisted reproductive procedures and maternal thrombophilia. Haematologica 88: 789-793.
63. Haggarty P, McCallum H, McBain H, Andrews K, Duthie S, et al. (2006) Effect of B vitamins and genetics on success of in-vitro fertilisation: prospective cohort study. Lancet 367: 1513-1519.
64. Coulam CB, Jeyendran RS, Fishel LA, Roussev R, (2006) Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage. Am J Reprod Immunol 55: 360-368.
65. Vialard F, El Sirkasi M, Tronchon V, Boudjenah R, Molina-Gomes D,et al. (Unpublished data) Increased embryo implantation rate in women with TNFalpha-308 polymorphism undergoing IVF for male infertility.
66. Goodman C, Jeyendran RS, Coulam CB, et al. (2008) Vascular endothelial growth factor gene polymorphism and implantation failure. Reprod Biomed Online 16: 720-723.